Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07028398

CMSL Ambulatory Sensitive Condition Nudge Study 2

The project aims to evaluate a nurse-led intervention to reduce inappropriate emergency department (ED) use among adult patients seen at Geisinger's Community Medicine Service Line (CMSL) clinics. The intervention occurs immediately following an appointment where a patient receives a diagnosis of an ambulatory sensitive condition (ASC; i.e., a condition considered to be a risk factor for near-term ED use). The evaluation will compare eligible patients with an ASC who were randomly assigned to receive follow-up outreach (patient portal message and/or call) from a nurse (who was automatically prompted via the Epic electronic health record system to initiate outreach) with those who were randomly assigned to receive standard care. Analyses will be intent-to-treat. The primary outcome is ED use in the week (i.e., 7 days) following the appointment.

We ran an earlier version of this intervention (NCT06798389). The current study is modified based on results and clinical guidance. Specifically, more conditions will be included as qualifying ASCs for enrollment. Patients under 30 will be excluded. And rather than calling all patients as in the original study, patient portal users may be contacted via the portal instead of or in addition to a phone call. Finally, in the first study, the intervention was differentially effective by age group (<45, 45-64, 65+). Our primary analysis will be conducted separately by age group, though we will also conduct an analysis combining across age groups.

We will run the study until we reach at least 4,330 patients in each of the following age groups: patients aged 30-45, patients aged 45-64, patients aged 65+. Therefore, our estimated sample size is at least 4,330x3 = 12,990.

We may be required to do an interim data pull and/or stop the study early at the direction of clinical or operational leaders.

Recruiting

Interested in participating?

Request Info

Key information

Age range

30 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Geisinger

Danville, Pennsylvania, 17821, United States

Location status: Recruiting

Location contact

Amir Goren, PhD

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 30 years +
  • Has a qualifying visit in CMSL with an ambulatory sensitive condition (ASC) encounter diagnosis

Treatment and study plan

Nurse Nudge

Behavioral

Nurses will be nudged to contact patients, which may increase the likelihood that the patient receives a post- appointment follow-up call and/or portal message.

Primary outcomes

  1. ED Visit (yes/no)

    Time frame: within 7 days post-appointment

    Visited the ED (y/n)

Other outcomes

  1. Nurse call to patient

    Time frame: Within 7 days post-appointment

    Nurse calls patient (y/n)

  2. Nurse message to patient

    Time frame: Within 7 days post-appointment

    Nurse sends MyChart message to patient (y/n)

  3. Nurse calls or sends message to patient

    Time frame: Within 7 days post-appointment

    Nurse calls or sends MyChart message to patient (y/n)

Study contacts

Contact information is provided by the study sponsor or research team.

Amir Goren, PhD

CONTACT

[email protected]

570-214-3495

Sponsors and collaborators

Lead sponsor

Geisinger Clinic

Other

Registry information

Official study title

Nurse Follow-up to Reduce Inappropriate Emergency Department Utilization in Adult Patients Seen for Ambulatory Sensitive Conditions in CMSL Study 2

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 19, 2025
Registry last updated
Feb 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.